DCGO Profit Breakdown

DocGo Inc. Profit Breakdown

Profit breakdown shows how much each product earned: one column per product, one row per year or quarter. All amounts are the filed figures for that period.

DocGo Inc. revenue for the quarter ending 2026-06-30 was $73.42M, a 8.70% decline year-over-year.
DocGo Inc. revenue for the quarter ending 2026-03-31 was $75.55M, a 21.33% decline year-over-year.
DocGo Inc. revenue for the quarter ending 2025-12-31 was $74.94M, a 37.98% decline year-over-year.
DocGo Inc. revenue for the quarter ending 2025-09-30 was $70.81M, a 48.94% decline year-over-year.
DocGo Inc. revenue for fiscal 2025 was $322.2M, a 47.74% decline from fiscal 2024.
DocGo Inc. revenue for fiscal 2024 was $616.56M, a 1.24% decline from fiscal 2023.
DocGo Inc. revenue for fiscal 2023 was $624.29M, a 41.72% increase from fiscal 2022.
DocGo Inc. revenue for fiscal 2022 was $440.52M, a 38.21% increase from fiscal 2021.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-06-30

Profit by product

Operating income: each quarter (3 month)

Quarter end	Mobile Health Services	Transportation Services
2026-06-30	-$5.25M	$348.09K
2025-06-30	-$615.35K	-$716.24K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
VSEE HEALTH, INC. (VSEE)	United States	$0.003B
Agape ATP Corp (ATPC)		$0.002B
Strata Critical Medical, Inc. (SRTA)	United States	$0.467B	11.33
InnovAge Holding Corp. (INNV)	United States	$1.206B	-635.60
Omada Health, Inc. (OMDA)	United States	$1.207B	309.08
U S PHYSICAL THERAPY INC /NV (USPH)	United States	$1.251B	32.48
Pennant Group, Inc. (PNTG)	United States	$1.386B	39.84
Privia Health Group, Inc. (PRVA)	United States	$2.477B	115.52
GeneDx Holdings Corp. (WGS)	United States	$2.638B	-19.23
LifeStance Health Group, Inc. (LFST)	United States	$4.510B	80.86